Ensign Peak Advisors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.74M | Buy |
|
|||||
|
2025
Q1 | $1.28M | Sell |
|
|||||
|
2024
Q4 | $14M | Sell |
|
|||||
|
2024
Q3 | $24.4M | Sell |
|
|||||
|
2024
Q2 | $25.1M | Buy |
|
|||||
|
2024
Q1 | $29.7M | Sell |
|
|||||
|
2023
Q4 | $35.6M | Hold |
|
|||||
|
2023
Q3 | $12.5M | Buy |
|
|||||
|
2023
Q2 | $11.5M | Hold |
|
|||||
|
2023
Q1 | $12.4M | Buy |
|
|||||
|
2022
Q4 | $15.7M | Buy |
|
|||||
|
2022
Q3 | $13.7M | Buy |
|
|||||
|
2022
Q2 | $9.34M | Buy |
|
|||||
|
2022
Q1 | $6.18M | Buy |
|
|||||
|
2021
Q4 | $7.2M | Sell |
|
|||||
|
2021
Q3 | $7.1M | Sell |
|
|||||
|
2021
Q2 | $4.01M | Buy |
|
|||||
|
2021
Q1 | $3.85M | Buy |
|
|||||
|
2020
Q4 | $1.55M | Sell |
|
|||||
|
2020
Q3 | $2.67M | Buy |
|
|||||
|
2020
Q2 | $1.75M | Hold |
|
|||||
|
2020
Q1 | $877K | Buy |
|
|||||
|
2019
Q4 | $699K | Buy |
|